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Abstract
Gastrointestinal stromal tumors (GISTs) are rare mesenchymal neoplasms of the gastrointestinal tract (1%), and
stomach is the most common location involved. However, the co-existence of gastric adenocarcinoma and GIST is
very rare. A case of an 80-year-old male with a simultaneous presentation of a gastric adenocarcinoma and GIST is
presented. Various hypotheses have been proposed in order to explain this rare simultaneous development, but
even though it’s cause has not been proven yet.
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Background
Gastrointestinal stromal tumors (GISTs) the commonest
non-epithelial tumors, are rare mesenchymal neoplasms
of the gastrointestinal tract, accounting only for 1% of
all gastrointestinal malignancies [1-3]. Interstitial cells of
Cajal, which are responsible for gut motility, is believed
to be GIST’s precursors, because both express the
receptor tyrosine kinase KIT (c-KIT) [4,5]. We present a
rare case of synchronous occurrence of adenocarcinoma
of the stomach in an 80-year-old male and GIST.
Case presentation
An 80-year-old male was admitted to our hospital com-
plaining about epigastric discomfort after meals, nausea
a n dw e i g h tl o s so fa b o u t8k gd u r i n gt h el a s tt h r e e
months. Mild anaemia was present, but physical exami-
nation and other laboratory tests were unremarkable.
Esophagogastroscopy revealed an ulcerative mass in the
gastric antrum on the lesser curvature measuring 4 × 6
cm. Pathology report of the endoscopic biopsies revealed
a well differentiated intestinal type gastric adenocarci-
noma. Chest and abdominal CT-scan for staging
demonstrated no sites of distant metastasis. The patient
underwent subtotal gastrectomy and Billroth-II
gastrojejunal anastomosis. During laparotomy a second
nodule was palpated about 3 cm proximal to the neo-
plasm at the lesser curvature. Pathology examination
confirmed the presence of a well differentiated intestinal
type gastric adenocarcinoma measuring 6,5 cm in dia-
meter, infiltrating the submucosa of the stomach (Figure
1), while none of the 21 resected lymph nodes contained
metastasis. The second lesion, however, was a 3 cm
GIST with intermediate malignant potential, having six
mitoses per 50 high power fields, but with severe
nuclear atypia and c-kit positive (Figure 2). The post-
operative course was uneventful and the patient was dis-
charged on the eighth postoperative day. The patient
received imatinib as adjuvant therapy for the GIST,
according to the international guidelines for GIST’sr i s k
stratification [1]. One year later on his follow up visit he
remains clinically and radiographically disease free.
GISTs are the most common non-epithelial tumors of
the digestive tract accounting for the 1% of all gastroin-
testinal malignancies and stomach is the most common
location involved (40-60%). They were previously
reported as leiomyomas, leiomyosarcomas, schwanno-
mas, but the last decade and after the implementation
of immunohistochemicals stains and electron micro-
scopy, these tumors have been recognized as distinct
pathological entity [1-6]. These tumors are believed to
originate from interstitial cells of Cajal or their
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protein (CD117), which is a type III tyrosine kinase
receptor encoded by the c-kit proto-ongogene [7]. These
tumors often express BCL-2 (80%), CD34 (70%), SMA
(35%), S-100 (10%) and desmin (5%) [8]. Based on that
expression GISTs are the first kind of tumors for which
targeted therapy was introduced, using imatinib, which
is an inhibitor of receptor tyrosine kinases including
KIT, platelet-derived growth factor receptors (PDGFRs),
colony stimulating factor 1 receptor (c-FMS), breakpoint
cluster region and abl gene fusion protein (BCR-ABL)
and specifically blocks the adenosine-5’-triphosphate
(ATP) binding site [9]. Rare cases of synchronous pre-
sentation of gastric adenocarcinoma and GIST have
been previously reported [10-13], but no convincing
explanation is still given for this coexistence. In our case
gastric adenocarcinoma and GIST’s site of occurrence
were different, however, collision tumors have also been
reported [14]. Simple coincidence could be the most
obvious explanation, but gene mutations or influenced
neighboring stomach tissues by the same carcinogen are
another two hypothesis reported in the literature
[10-15]. A combined genetic deregulation seems to be
involved in the pathogenesis of these two entities. Surgi-
cal excision is the therapeutic approach for both of
them following oncologic principles. The postoperative
adjuvant therapy should include either chemotherapy
for the adenocarcinoma, depending on the pathology
report and disease stage and/or imatinib for the GIST
depending on the risk category stratification according
to the international guidelines.
Conclusions
Concurrent existence of gastric adenocarcinoma and
GIST is a rare case and proven relation of this synchro-
nous development has not been established. High clini-
cal suspicion during laparotomy for another reason is
required in order to detect GISTs, because they are
asymptomatic and incidental findings most of the times.
Surgical excision is the mainstay of therapy and further
research is needed for explaining this simultaneous
tumor development, if there is such.
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